Telehealth Group Intervention for Perinatal Depressive Symptoms
TePOP
Randomized Trial of Telehealth Group Intervention to Reduce Perinatal Depressive Symptoms in Diverse Populations
2 other identifiers
interventional
99
1 country
1
Brief Summary
The goal of the project is to evaluate for the first time, the effectiveness of using a telehealth approach to reducing perinatal depressive symptoms in diverse groups of childbearing women; urban and rural-dwelling, and from Hispanic and predominantly North European Descent populations. Pregnant women connect for one hour weekly, for 8 weeks, using their own electronic device, from whatever location they choose (e.g. home), to attend videoconference groups facilitated by a mental health professional. The approach is cost effective and reduces barriers to access to mental health services, particularly for women living in rural, low-resource, and minority communities, and those without adequate transportation, financial resources, childcare, or work release time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2019
CompletedFirst Posted
Study publicly available on registry
May 1, 2019
CompletedStudy Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedResults Posted
Study results publicly available
June 4, 2024
CompletedJune 4, 2024
May 1, 2024
2.8 years
April 16, 2019
August 23, 2023
May 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Depressive Symptoms Over Time
Self-completed: Edinburgh Postnatal Depression Scale measures depression symptoms during pregnancy and postpartum. The instrument will measure depressive symptoms at 6 time points during pregnancy and postpartum. The instrument is on a scale of 0-30, with 0 indicating no symptoms, and 30 indicating the highest severity of symptoms. Scores \< 10 = no depressive symptoms; 10-15 = mild; 16-20 = moderate; \> 20 = severe.
Time 1 = pre-intervention (Baseline); T2 = immediately following week 9 of group intervention classes (Post), T3= 2 months post-intervention; T4= 4 months post-intervention; T5 = 6 months post-intervention; T6 = 8 post-intervention
Secondary Outcomes (1)
Change in Anxiety Symptoms Over Time
Time 1 = pre-intervention; T2 = immediately following week 9 of group intervention classes (post-intervention), T3= 2 months post-intervention; T4= 4 months post-intervention; T5 = 6 months post-intervention; T6 = 8 post-intervention
Study Arms (2)
UPLIFT Program
EXPERIMENTALWeekly one-hour group sessions for 10 weeks facilitated by a mental health professional.
Pregnancy Skills Group
ACTIVE COMPARATORWeekly one-hour group sessions for 10 weeks facilitated by a registered nurse.
Interventions
UPLIFT is based on cognitive behavioral therapy and mindfulness-based practices. Participants meet by videoconference using any electronic device (laptop, tablet, smart phone) from their own home.
Program is based on standard prenatal, childbirth, infant feeding, and parenting education curriculum. Participants meet by videoconference using any electronic device (laptop, tablet, smart phone) from their own home.
Eligibility Criteria
You may qualify if:
- women age 18 and older
- have a viable pregnancy (any gestational age) or postpartum (up to 6 months)
- have an Edinburgh Postpartum Depression Scale (EPDS) score between 9 and 20
- are English or Spanish speaking
- are receiving clinical services at a collaborating prenatal or public health clinic associated with the U of Utah or Utah rural Health Districts
You may not qualify if:
- women who have an EPDS score less than 9 or greater than 20
- have a current diagnosis of a serious mental illness, such as psychosis, schizophrenia, bipolar disorder, severe depression, suicidal ideation, homicidal ideation
- begun taking or changed dosage of any medications for a mental health condition within the previous 6 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- National Institute of Nursing Research (NINR)collaborator
Study Sites (1)
University of Utah
Salt Lake City, Utah, 84112, United States
Related Publications (1)
Iacob E, Kausler R, Williams M, Simonsen S, Smid M, Weissinger K, Latendresse G. Protocol for a randomized controlled trial to evaluate the effectiveness of a telehealth group intervention to reduce perinatal depressive symptoms. Contemp Clin Trials. 2024 Dec;147:107738. doi: 10.1016/j.cct.2024.107738. Epub 2024 Nov 13.
PMID: 39542133DERIVED
Limitations and Caveats
Limitations included low recruitment (largely due to COVID-19), difficulty in identifying participation in either group as the cause of lower EPDS scores 8 months after participation, and difficulty in accounting for factors impacting personal changes that can occur in the 10 months of involvement in the study.
Results Point of Contact
- Title
- Gwen Latendresse
- Organization
- University of Utah
Study Officials
- PRINCIPAL INVESTIGATOR
Gwen Latendresse, PhD
University of Utah
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assitant Dean, Associate Professor
Study Record Dates
First Submitted
April 16, 2019
First Posted
May 1, 2019
Study Start
May 1, 2020
Primary Completion
March 1, 2023
Study Completion
March 1, 2023
Last Updated
June 4, 2024
Results First Posted
June 4, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- The PI agrees to make available data within one year of the completion of the funded project period
- Access Criteria
- Data will be shared with investigators working under an institution with a Federal Wide Assurance (FWA) and can be used for secondary study purposes.
The PI will share de-identified data to other investigators for study, including demographics, outcomes, communication methodology, and design. Data will be shared with investigators working under an institution with a Federal Wide Assurance (FWA) and can be used for secondary study purposes. The PI agrees to make available data within one year of the completion of the funded project period and manuscripts pertaining to the aims. The PI agrees to share data in a manner that is fully consistent with NIH data sharing policies and applicable laws and regulations.